A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis. Issue 3 (3rd April 2018)
- Record Type:
- Journal Article
- Title:
- A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis. Issue 3 (3rd April 2018)
- Main Title:
- A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis
- Authors:
- Clawson, Lora L.
Cudkowicz, Merit
Krivickas, Lisa
Brooks, Benjamin R.
Sanjak, Mohammed
Allred, Peggy
Atassi, Nazem
Swartz, Amy
Steinhorn, Gabrielle
Uchil, Alpa
Riley, Kristen M.
Yu, Hong
Schoenfeld, David A.
Maragakis, Nicholas J. - Abstract:
- Abstract: Objective: Evaluate the safety and tolerability of resistance and endurance exercise in ALS participants as measured by their ability to complete this six-month study. Methods: Participants were randomized to Resistance, Endurance, or Stretching/Range of Motion (SROM the exercise regimen prescribed for most ALS patients) exercises. All exercises were performed at home with an individualized regimen designed by a physical therapist trained in ALS management. Primary outcome measures were tolerability of the exercises at 24 weeks defined by 50% of participants completing at least 50% of the prescribed exercise regimen. Secondary outcome measures included the ALSFRS-R, pulmonary FVC, and other measures of ALS function. Results: At 12 and 24 weeks, all three exercise regimens were tolerated according to our pre-specified criteria. Compliance to the prescribed exercise regimen was the highest in the resistance and SROM arms of the study. All three forms of exercise were considered safe as there were no differences in the rates of disease progression among groups. There were no differences in the secondary outcome measures and feasibility for evaluating these measures was successful. In a post-hoc analysis, there was a trend towards fewer falls in the Resistance and Endurance groups. Conclusions: This study demonstrates that SROM, resistance, and endurance exercise are all safe to be performed with the specified regimen without any worsening of outcomes as related to ALSAbstract: Objective: Evaluate the safety and tolerability of resistance and endurance exercise in ALS participants as measured by their ability to complete this six-month study. Methods: Participants were randomized to Resistance, Endurance, or Stretching/Range of Motion (SROM the exercise regimen prescribed for most ALS patients) exercises. All exercises were performed at home with an individualized regimen designed by a physical therapist trained in ALS management. Primary outcome measures were tolerability of the exercises at 24 weeks defined by 50% of participants completing at least 50% of the prescribed exercise regimen. Secondary outcome measures included the ALSFRS-R, pulmonary FVC, and other measures of ALS function. Results: At 12 and 24 weeks, all three exercise regimens were tolerated according to our pre-specified criteria. Compliance to the prescribed exercise regimen was the highest in the resistance and SROM arms of the study. All three forms of exercise were considered safe as there were no differences in the rates of disease progression among groups. There were no differences in the secondary outcome measures and feasibility for evaluating these measures was successful. In a post-hoc analysis, there was a trend towards fewer falls in the Resistance and Endurance groups. Conclusions: This study demonstrates that SROM, resistance, and endurance exercise are all safe to be performed with the specified regimen without any worsening of outcomes as related to ALS function. All three forms of exercise were tolerated with resistance and SROM exercises showing the highest compliance over the 24 week-period. … (more)
- Is Part Of:
- Amyotrophic lateral sclerosis and frontotemporal degeneration. Volume 19:Issue 3/4(2018)
- Journal:
- Amyotrophic lateral sclerosis and frontotemporal degeneration
- Issue:
- Volume 19:Issue 3/4(2018)
- Issue Display:
- Volume 19, Issue 3/4 (2018)
- Year:
- 2018
- Volume:
- 19
- Issue:
- 3/4
- Issue Sort Value:
- 2018-0019-NaN-0000
- Page Start:
- 250
- Page End:
- 258
- Publication Date:
- 2018-04-03
- Subjects:
- ALS -- tolerability -- benefit -- motor neuron disease -- clinical trial
616.839 - Journal URLs:
- http://informahealthcare.com/journal/afd ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/21678421.2017.1404108 ↗
- Languages:
- English
- ISSNs:
- 2167-8421
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0859.841188
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6169.xml